Anne Bregnhøj

Anne Bregnhøj

Auto-generated profile, based on publicly available information

Anne Bregnhøj

Department of Dermatology Aarhus University Hospital Aarhus Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2021 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ABA. Bregnhøj
A. Bregnhøj
KTK.K.H. Thuesen
K.K.H. Thuesen
TEThomas Emmanuel
Thomas Emmanuel
Thomas LitmanThomas Litman
Thomas Litman
CGC.L. Grek
C.L. Grek
LILars Iversen
Lars Iversen

Verified
Journal Article
Open access
PDF file
TEThomas Emmanuel
Thomas Emmanuel
JMJosephine Mistegård
Josephine Mistegård
ABAnne Bregnhøj
Anne Bregnhøj
CJClaus Johansen
Claus Johansen
LILars Iversen
Lars Iversen
In health, the non-recirculating nature and long-term persistence of tissue-resident memory T cells (TRMs) in tissues protects against invading pathogens. In disease, pathogenic TRMs contribute to the recurring traits of many skin diseases. We aimed to conduct a systematic literature review on the current understanding of the role of TRMs in skin diseases and identify gaps as well as future research paths. EMBASE, PubMed, SCOPUS, Web of Science, Clinicaltrials.gov and WHO Trials Registry were searched systematically for relevant studies from their inception to October 2020. Included studies were reviewed independently by two authors. This study was conducted in accordance with the PRISMA-S guidelines. This protocol was registered with the PROSPERO database (ref: CRD42020206416). We identified 96 studies meeting the inclusion criteria. TRMs have mostly been investigated in murine skin and in relation to infectious skin diseases. Pathogenic TRMs have been characterized in various skin diseases including psoriasis, vitiligo and cutaneous T-cell lymphoma. Studies are needed to discover biomarkers that may delineate TRMs poised for pathogenic activity in skin diseases and establish to which extent TRMs are contingent on the local skin microenvironment. Additionally, future studies may investigate the effects of current treatments on the persistence of pathogenic TRMs in human skin.

Verified
Journal Article
Open access
PDF file
HAHakim Ben Abdallah
Hakim Ben Abdallah
ABAnne Bregnhøj
Anne Bregnhøj
LILars Iversen
Lars Iversen
CJClaus Johansen
Claus Johansen
Hidradenitis suppurativa is a chronic inflammatory skin disease with limited treatment options. The poorly understood pathogenesis hinders the development of effective treatments; therefore, a pressing need exists to further elucidate the molecular mechanisms in hidradenitis suppurativa. This study investigated the underlying inflammatory pathways and cell types in hidradenitis suppurativa using transcriptomic approaches with RNA sequencing of lesional and non-lesional skin biopsies from hidradenitis suppurativa, which was jointly analyzed with previously published transcriptomic data from atopic dermatitis and psoriasis patients. The differential expression and pathway enrichment analyses demonstrated the activation of multiple inflammatory processes, including the innate and adaptive immune systems, implicated in the hidradenitis suppurativa pathogenesis. In agreement, hidradenitis suppurativa exhibited a unique and heterogeneous cell type signature involving lymphoid and myeloid cells such as B cells and macrophages. Furthermore, hidradenitis suppurativa displayed increased expression of TH1/2/17 signatures with no predominant TH signatures unlike psoriasis (TH1/17) and atopic dermatitis (TH2). In summary, our study provides molecular insights into the pathomechanisms in hidradenitis suppurativa, revealing a strong and widespread immune activation, which may benefit from treatment strategies offering a broad immunomodulation of various key inflammatory pathways. Our data not only corroborate previously reported findings but also enhance our understanding of the immune dysregulation in hidradenitis suppurativa, uncovering novel and potential therapeutic targets.

6 January 2011 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
ABAnne Bregnhøj
Anne Bregnhøj
HSHeidi Søsted
Heidi Søsted
TMTorkil Menné
Torkil Menné
JJJeanne Duus Johansen
Jeanne Duus Johansen

13 June 2022 in Contact Dermatitis
Verified
Journal Article
Closed access
CSCatarina Alves da Silva
Catarina Alves da Silva
ABAnne Bregnhøj
Anne Bregnhøj
MMMartin Mowitz
Martin Mowitz
MBMagnus Bruze
Magnus Bruze
KAKlaus Ejner Andersen
Klaus Ejner Andersen
MSMette Sommerlund
Mette Sommerlund

27 February 2022 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
TEThomas Emmanuel
Thomas Emmanuel
APAnnita Petersen
Annita Petersen
HHHannah Inez Houborg
Hannah Inez Houborg
ARAnders Benjamin Rønsholdt
Anders Benjamin Rønsholdt
DLDorte Lybæk
Dorte Lybæk
CJClaus Johansen
Claus Johansen
Background Climatotherapy is a well-described treatment of psoriasis. Dead Sea climatotherapy (DSC) in Israel consists of intensive sun and Dead Sea bathing and is very effective in improving clinical and patient-reported outcomes. However, the effect of DSC has not been widely studied. We aimed to investigate the effect of DSC on psoriasis skin using quantitative immunohistochemistry techniques and analysis of blood samples. Methods Skin punch biopsies from 18 psoriasis patients from a previous cohort study were used. Biopsies were obtained from non-lesional skin and from a psoriasis target lesion at baseline. A biopsy was acquired from the target lesion after DSC. Among patients who achieved complete visual clearance, a biopsy was also obtained at relapse. Blood samples were obtained at the same time points. We performed haematoxylin and eosin staining and quantitative immunohistochemical analysis of CD3, CD4, CD8, CD11c, CD103, CD163, CD207, forkhead box P3, Ki67, and myeloperoxidase. We performed blood tests of cholesterol, c-reactive protein, glucose, haemoglobin A1c and triglycerides. Results All skin biomarkers except for CD207 were decreased after DSC. At relapse, none of the biomarkers were significantly different from the baseline lesional measurements. Total CD207 staining correlated with psoriasis area and severity index at baseline while CD163 staining correlated with psoriasis area and severity index at EOT. No changes were observed in selected blood tests during the study. Conclusion Consistent with clinical results, DSC is highly effective in the short term almost normalising all investigated biomarkers. However, at relapse, biomarkers were upregulated to the baseline level.